Review Article
Volume 7 Issue 2 - 2020
Cardiovascular Disease and Health
Chakrapani BS1*, Mukul R Fulmali2
1Senior Consultant Cardiologist, Bangalore, India
2Consultant Cardiologist, Bangalore, India
*Corresponding Author: Chakrapani BS, Senior Consultant Cardiologist, Bangalore, India.
Received: December 23, 2019; Published: January 10, 2020




Abstract

Introduction: The purpose of writing this article is to emphasize the fact that, in the era of gadgets and high end diagnostic facility to diagnose CAD, the epidemiological modules still have an upper hand in diagnosing CAD. The epidemiological data is easily applicable, adaptable, accessible, affordable and large section of population can be covered at one stroke by stratifying the given population into low risk, intermediate risk and high risk. Accordingly, Clinician can advise regarding future course of action. This article is supported by our observational study done in our institute which echoes the epidemiological data. These highly effective modules are also low cost and highly applicable. These also help the policy makers to focus on preventive measures to curtail growing no of CAD patients so that young life can be saved and loss of man hours and productivity can be saved.

We did one observational study 1 to determine risk factors in patients with premature CAD, the same is presented below and review of literature for the said risk factor is done.

Purpose: Asian Indians - those living in India and also the Diasporas have one of the highest rates of coronary artery disease in the world. Among urban Indians the prevalence of CAD is around 10 - 12%.

Aims: To study the risk factors in patients with premature CAD.

Study Design: A prospective observational study was performed to determine cardiovascular risk factors in patients with premature CAD in India.

Methods: All patients with premature coronary artery disease i.e. males < 55 yrs age and females < 65 yrs age were included in the study. The risks factors were assessed in all these patients.

Results: Total 416 patients were taken in the study, 335 were males (80.53%) and 81were females (19.47%). The mean age was found to be 48.45 yrs. The youngest patient was 20 years of age. Low fruits and vegetables in the diet (78.85%), smoking (45.91%), high dietary fat intake (45.67%) were the most frequent risks factors. 47.6% of the patients were on predominantly non vegetarian diet. Family history of CAD was found in 22.12% of the patients. Co morbidities, 50.96% were hypertensive, 50% patients had preexisting diabetes, 25.96% were dyslipidemia and 6.73% hypothyroid on admission. 67.41% patients were in Killip class I, 26.67% in class II, 2.96% in class III and 2.96% in class IV. 68.02% had STEMI, 13.46% had NSTEMI and 9.62% had CSA 8.89% had UA. On coronary angiography 44.47% had SVD, 23.32% DVD 26.20% had TVD and 6.01% had minor CAD. Majority i.e. 53.85% underwent primary PCI, 17.31% were advised elective PCI, 3.13% had recanalized vessel, 2.64% underwent thrombolytic, 10.10% was treated medically and for 12.98% CABG was done.

Conclusion: 1) Smoking is one of the major risk factor for premature CAD. 2) Improper dietary habits are seen in majority of premature CAD patients.

Keywords: Cardiovascular Disease; Hyperlipidemia; Coronary Artery Disease

References

  1. “Risk factors in Indian patients with Premature Coronary artery disease-Hospital based observational study”. Thesis submitted to the National Board of Examination for Diplomat of National Board in Cardiology by Mukul R. Fulmali under the guidance of Chakrapani BS (2017).
  2. World health Organisation. “Global a status report on non communicable disease 2010”. Geneva, Switzerland: world health Organisation (2011).
  3. Miller T. “Global, regional, and National age- sex specific all cause and cause specific mortality for240 causes of death, 1993-2013: a systematic analysis for the Global burden of Disease study 2013”. Lancet 385 (2015): 117-171.
  4. Bloom DE., et al. “Global economic burden of no communicable diseases”. Programme on the Global Demography of Aging”. World Economic forum (2011).
  5. Roth GA., et al. “Global and regional patterns in cardiovascular mortality from 1990 to 2013”. Circulation 132 (2015): 1667-1678.
  6. Mensah GA., et al. “Global burden of cardiovascular disease, 1990-2010”. Global Heart 9 (2014): 183-184.
  7. Roth GA., et al. “Demographic and epediomological drivers of global cardiovascular mortality”. The New England Journal of Medicine 372 (2015): 1333-1341.
  8. Moran AE., et al. “Variation in ischemic heart disease by age, country, and income: Global burden of Diseases, Injuries, and Risk Factors 2010 study”. Global Heart 9 (2014): 91-99.
  9. Goundurao., et al. “Epidemiological study of CAD in Urban population of Delhi”. Indian Journal of Medical Research 92 (1990): 424-430.
  10. Gupta R., et al. “Prevalence of CAD and Coronary risk factors in an urban population of Rajasthan”. Indian Heart Journal 47 (1995): 331-338.
  11. Destefero F., et al. “Trends in CAD in the US 1980 through 1989”. Archives of Internal Medicine 153 (1993): 2489-2894.
  12. Begorn R and Singh RB. “Prevalence of CAD and risk factors in urban population of South India and North india”. Acta Cardiologica 3 (1995): 227-240.
  13. Dawber TR and Framingham. “Study: The epidemiology of atherosclerotic disease”. Cambridge Harvard University press and Commonwealth fund Mass: London (1980).
  14. Shaper AG., et al. “Risk factors for IHD The prospective phase of the British regional Heart study’s”. Epidemiology community Health 39 (1985): 197-209.
  15. Martin MJ., et al. “Serum cholesterol, blood pressure and mortality implications from a cohort of 361662 men”. Lancet (1986): 933-936.
  16. Dahlen GH., et al. “Association of levels of Lip[protein (a),Plasma lipids and other Lipoproteins with CAD documented by Angiography”. Circulation 74 (1986): 758.
  17. Rhoads GG., et al. “Lipoprotein (a) as a risk factor for Myocardial infarction”. JAMA 256 (1986): 2540.
  18. Stout RN. “Blood glucose and atherosclerosis”. Arteriosclerosis 1 (1981): 227-234.
  19. Dhawan J. “Observation on the CAD in Asians”. Doctor of Medicine thesis, University of Manchester (1991). 
  20. World Health Report. “Reducing risk and promoting healthy life style”. Geneva, World Health Organisation (2002).
  21. Jha P., et al. “Tobacco addiction Disease control priorities in Developing countries”. 2nd edition, Newyork, Oxford university press 2006.
  22. Mackay J and Mensah G. “Atlas of heart disease and stroke”. Geneva World Health Organisation (2004).
  23. The Global Youth Tobacco Survey collaborative group. “Tobacco use among youth, across country comparison”. Tobacco Control 11 (2002): 252.
  24. Liu BQ., et al. “Emerging tobacco hazards in china. 1. Retrospective Proportional mortality study of one million deaths”. BMJ 317 (1998): 1411.
  25. Kennedy ET and Bowman SA. “Powel R Dietary fat intake in the US population”. Journal of the American College of Nutrition 18 (1999): 207.
  26. Centers for Disease Control and Prevention (CDC). “Physical activity trend-United states, 1990-1998”. Morbidity and Mortality Weekly Report 50 (2001): 166.
  27. Wang L., et al. “Preventing chronic disease in china”. Lancet 366 (2005): 1821.
  28. Yusuf S., et al. “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study”. Lancet 364 (2004): 937.
  29. Erasmus RT., et al. “Plasma cholesterol distribution in rural Nigerian population-relationship to age, sex, and body mass”. Central African Journal of Medicine 40 (1994): 299.
  30. Caroll MD., et al. “Trends in serum lipids and lipoproteins of adults, 1960-2002”. JAMA 294 (2005): 1773.
  31. Kuzuya M., et al. “Changes in serum lipids during 10 year periods in a large Japanese population. A cross sectional and longitudinal study”. Atherosclerosis 163 (2005): 313.
  32. Khoo KL., et al. “Lipids and coronary heart disease in Asia”. Atherosclerosis 169 (2003): 1.
  33. Keil U and Kuulasman K. “WHO MONICA Project: Risk factors”. International Journal of Epidemiology 18 (1989): s 46.
  34. Grundy SM., et al. “AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines”. Circulation 139 (2019): e1082-1143.
  35. van den Hoogen PC., et al. “The relation between blood pressure and mortality due to coronary heart disease among men in different parts of world. Seven study Research group”. The New England Journal of Medicine 342 (2000): 1.
  36. Goff DC Jr., et al. “ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. Circulation 129.2 (2014): S49-S73.
  37. Narayan KM., et al. “Diabetes: The pandemic and potential solutions”. Disease control priorities in developing Countries. 2nd Edition Washington.
  38. Whelton PK., et al. “2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines”. Hypertension 71 (2018): 1269-1324. 
  39. Grundy SM., et al. “2018 AHA/ACC/AACVPR/AAPA/ABC/ ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines”. Circulation 139 (2019): e1082-1143.
  40. D’Agostino RB Sr., et al. “General cardiovascular risk profile for use in primary care: the Framingham Heart Study”. Circulation 117 (2008): 743-753.
  41. Ridker PM., et al. “Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score”. JAMA 297 (2007): 611-619.
  42. Ridker PM., et al. “C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men”. Circulation 118 (2008): 2243-2251.
  43. Volgman AS., et al. “Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association”. Circulation 138 (2018): e1-34.
  44. The Multi-Ethnic Study of Atherosclerosis. CAC Score Reference Values.
Citation: Chakrapani BS and Mukul R Fulmali. “Cardiovascular Disease and Health”. EC Cardiology 7.2 (2020): 01-08.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


June Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the June issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for August Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the August issue of respective journals. Submissions are accepted on/before July 13, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk